Farther Finance Advisors’s Tourmaline Bio TRML Stock Holding History

Farther Finance Advisors’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,146	Closed	-$103K	–	5590
2025 Q3	$103K	Buy	2,146 +1,144	+114%	+$31.7K	﹤0.01%	2029
2025 Q2	$16K	Sell	1,002 -657	-40%	-$10.6K	﹤0.01%	2816
2025 Q1	$23.6K	Buy	+1,659	New	+$26.6K	﹤0.01%	2304

Farther Finance Advisors's TRML Position: Q4 2025 in Review

Farther Finance Advisors sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 2,146 shares — an estimated $103K sold.

Farther Finance Advisors first reported a position in TRML in Q1 2025 and held it in 3 quarters. The position peaked at $103K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Farther Finance Advisors reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Farther Finance Advisors sold 2,146 Tourmaline Bio shares in Q4 2025, an estimated $103K.
Farther Finance Advisors first reported a position in Tourmaline Bio in Q1 2025 and held it in 3 quarters.
Farther Finance Advisors's Tourmaline Bio position peaked at $103K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Farther Finance Advisors's 13F filing for Q4 2025, filed 23 Jan 2026.